Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
Andrea KallmeyerAna PelloEster CánovasÁlvaro AceñaMaría Luisa González-CasausNieves TarínCarmen CristóbalCarlos Gutiérrez-LandaluceAna HuelmosAida Rodríguez-ValerÓscar González-LorenzoJoaquín AlonsoLorenzo López-BescósJesús EgidoIgnacio MahilloÓscar LorenzoJosé TuñónPublished in: ESC heart failure (2023)
FGF23 and other components of MM are independent predictors of HF and death after an ACS. This effect is homogeneous across different subgroups of population, and it is not limited to patients with chronic kidney disease.